Dr. Eva A. Hurst, MD

Dr. Hurst practices at Distinctive Dermatologyltd in Fairview Heights, Illinois.

Dr. Hurst's NPI, 1023220464, was assigned on May 6, 2007. Dr. Hurst graduated from Washington University School of Medicine in 2002. Dr. Hurst holds Missouri license 2007020114.

Dr. Hurst's primary practice is Distinctive Dermatologyltd, at 390 Office Ct, Fairview Heights, IL 62208-2059. The practice phone is (618) 233-7666.

Dr. Hurst's primary practice is Distinctive Dermatologyltd in Fairview Heights, Illinois. Dr. Hurst is also affiliated with Memorial Hospital in Belleville. The medical group on file is Distinctive Dermatology. Dmand AI also links Dr. Hurst to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hurst practices, 2 sites in all. Vendor and product names are available with a free account.

Clinical and laboratory dermatological immunology is Dr. Hurst's primary specialty in the NPI Registry, under taxonomy code 207NI0002X. Dr. Hurst is board certified in dermatology by the American Board of Dermatology. Dr. Hurst is licensed in Missouri.

CMS data shows 3,281 Medicare services from Dr. Hurst across 24 procedure codes in 2024, for 568 Medicare patients. Medicare paid $2,321,392 for them. Every service was in an office.

CMS counts 568 Medicare patients who saw Dr. Hurst in 2024. The largest group is 75 to 84, with 230 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hurst's median patient age at 76, with 40% women.

In 2024, Dr. Hurst wrote 140 Medicare Part D claims for 119 patients. 100% of them were for generic drugs. CMS names the drug for 108 of them, across 5 drugs with 11 or more claims each, at $729 in total drug cost. In 2023, CMS named 98 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Hurst for performance year 2024, reported as part of a group. Dr. Hurst accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 186 procedures of melanoma (skin cancer) excision by Dr. Hurst, more than 97% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 33 papers to Dr. Hurst, published from 2012 to 2024. 2014 was the busiest year, with 2. The most frequent topics are Skin Neoplasms, Mohs Surgery and Carcinoma, Basal Cell. Dr. Hurst has published most often in Dermatol Surg. Dr. Hurst's most frequent co-authors are Sanjana Iyengar, MD, Ian A. Maher, MD and Stanley Joseph Miller, MD.

CMS Open Payments shows 283 general payments to Dr. Hurst from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Abbvie Inc. paid the most, $770.

Dr. Hurst graduated from Washington University School of Medicine in 2002.